STAT6 polymorphism was correlated with gefitinib-induced diarrhea in patients with non-small cell lung cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e21046
Abstract: e21046 Background: Gefitinib-induced diarrhea can be severe, if not properly handled, and can result in severe dose reductions and treatment interruptions or discontinuation. However, the mechanism of gefitinib-induced diarrhea remains unclear. STAT6 promotes disruption of… read more here.
Keywords: stat6 rs167769; gefitinib; gefitinib induced; induced diarrhea ... See more keywords